Andrew Zapfel/ Global Action Network for Sickle Cell & Other Inherited Blood Disorders
Sep 16, 2026, 13:38
Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
Andrew Zapfel, Deputy Director, Global SCD Initiatives and Alliances at American Society of Hematology, shared a post on LinkedIn:
“Together, we can transform the future of sickle cell disease!
I’m proud to be part of the work for the American Society of Hematology, celebrating over 10 years of impact.
Right now, donations to the ASH SCD Initiative Fund are being matched dollar for dollar up to $10,000!
Every dollar goes to support programs like training healthcare professionals in low resource settings, raising awareness of SCD among the general population, and improving patient facing tools.
Let’s meet, and exceed, our goal for ASH Foundation donations.”
Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery